Skip to main content

Advertisement

Log in

Epstein-Barr Virus-Positive Large Cell Neuroendocrine Carcinoma of the Nasopharynx: Report of a Case with Complete Clinical and Radiological Response After Combined Chemoradiotherapy

  • Case Report
  • Published:
Head and Neck Pathology Aims and scope Submit manuscript

Abstract

Neuroendocrine carcinomas of the head and neck are rare and are classified as well differentiated, moderately differentiated, and poorly differentiated carcinomas with the latter category being subdivided into small cell and large cell neuroendocrine carcinoma (LCNEC). While most carcinomas in the nasopharynx are associated with Epstein-Barr virus (EBV), there has been only one previous report demonstrating a link between EBV and LCNEC of the nasopharynx. In this report we describe a second case of EBV-positive LCNEC arising in the nasopharynx with bilateral cervical metastases. The patient was treated with a combination of radiation and chemotherapy which resulted in a complete clinical and radiological response. The patient is still disease free 3 years after presentation. The results of this case suggest that EBV-positive LCNEC is sensitive to chemoradiotherapy and as a result may have better prognosis than EBV-negative LCNEC arising in the nasopharynx or other sites.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. El-Naggar AK, Chan JKC, Grandis JR, Takata T, Slootweg PJ, editors. WHO classification of head and neck tumours. IARC: Lyon; 2017.

    Google Scholar 

  2. Kraft S, Faquin WC, Krane JF. HPV-associated Neuroendocrine Carcinoma of the Oropharynx. Am J Surg Pathol. 2012;36:321–30.

    Article  Google Scholar 

  3. Bates T, Mcqueen A, Iqbal MS, Kelly C, Robinson M. Small cell neuroendocrine carcinoma of the oropharynx harbouring oncogenic HPV-infection. Head Neck Pathol. 2013;8:127–31.

    Article  Google Scholar 

  4. Chua MLK, Wee JTS, Hui EP, Chan ATC. Nasopharyngeal carcinoma. Lancet. 2016;387:1012–24.

    Article  Google Scholar 

  5. Kao H-L, Chang W-C, Li W-Y, Li AC-H, Li AF-Y. Head and neck large cell neuroendocrine carcinoma should be separated from atypical carcinoid on the basis of different clinical features, overall survival, and pathogenesis. Am J Surg Pathol. 2012;36:185–92.

    Article  Google Scholar 

  6. Travis WD. Pathology and diagnosis of neuroendocrine tumors. Thorac Surg Clin. 2014;24:257–66.

    Article  Google Scholar 

  7. Elloumi F, Fourati N, Siala W, Ghorbell L, Jlidi R, Ghorbel A, et al. Tumeur neuroendocrine à grandes cellules du nasopharynx: à propos d’un cas. Cancer/Radiothérapie. 2014;18:208–10.

    Article  CAS  Google Scholar 

  8. Sturgis CD, Burkey BB, Momin S, Hoschar AP. High grade (large cell) neuroendocrine carcinoma of the nasopharynx: novel case report with touch preparation cytology and positive EBV encoded early RNA. Case Rep Pathol. 2015;2015:1–4.

    Article  Google Scholar 

  9. Dumars C, Thebaud E, Joubert M, Renaudin K, Cariou-Patron G, Heymann M-F. Large cell neuroendocrine carcinoma of the nasopharynx. J Pediatric Hematol/Oncol. 2015;37:474–6.

    Article  Google Scholar 

  10. Petersson F. Nasopharyngeal carcinoma: a review. Semin Diagn Pathol. 2015;32:54–73.

    Article  Google Scholar 

  11. Iyoda A, Makino T, Koezuka S, Otsuka H, Hata Y. Treatment options for patients with large cell neuroendocrine carcinoma of the lung. General Thorac Cardiovasc Surg. 2014;62:351–6.

    Article  Google Scholar 

  12. Iyoda A, Hiroshima K, Moriya Y, Takiguchi Y, Sekine Y, Shibuya K, et al. Prospective Study of adjuvant chemotherapy for pulmonary large cell neuroendocrine carcinoma. Ann Thorac Surg. 2006;82:1802–7.

    Article  Google Scholar 

  13. Sarkaria IS, Iyoda A, Roh MS, Sica G, Kuk D, Sima CS, et al. Neoadjuvant and adjuvant chemotherapy in resected pulmonary large cell neuroendocrine carcinomas: a single institution experience. Ann Thorac Surg. 2011;92:1180–7.

    Article  Google Scholar 

  14. Laan TPVD, Plaat BEC, Laan BFVD, Halmos GB. Clinical recommendations on the treatment of neuroendocrine carcinoma of the larynx: a meta-analysis of 436 reported cases. Head Neck. 2014;37:707–15.

    Article  Google Scholar 

  15. Lee AW, Ma BB, Ng WT, Chan AT. Management of nasopharyngeal carcinoma: current practice and future perspective. J Clin Oncol. 2015;33:3356–64.

    Article  Google Scholar 

  16. Gao W, Li Z-H, Chen S, Chan JY-W, Yin M, Zhang M-J, et al. Epstein-Barr virus encoded microRNA BART7 regulates radiation sensitivity of nasopharyngeal carcinoma. Oncotarget. 2017;8:20297.

    Article  Google Scholar 

  17. Dworakowska D, Grossman AB. Are neuroendocrine tumours a feature of tuberous sclerosis? A systematic review. Endocr Relat Cancer. 2009;16:45–58.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Bayardo Perez-Ordóñez.

Ethics declarations

Conflict of interest

None of the authors have any conflicts of interest to declare.

Informed Consent

Informed consent was received from the patient described in this case in compliance with institutional standards prior to initiating this study.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Wasserman, J.K., Papp, S., Hope, A.J. et al. Epstein-Barr Virus-Positive Large Cell Neuroendocrine Carcinoma of the Nasopharynx: Report of a Case with Complete Clinical and Radiological Response After Combined Chemoradiotherapy. Head and Neck Pathol 12, 587–591 (2018). https://doi.org/10.1007/s12105-017-0883-1

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12105-017-0883-1

Keywords

Navigation